Syncom Formulation (India) Ltd.

BSE: 524470

Falling Comet

Download real time

15.42 -0.15 (-0.96%)

44.81% Fall from 52W High

1.6M NSE+BSE Volume

BSE 07 May, 2025 10:11 AM (IST)

1,449.5

Market Cap

Above industry Median

1.2

Beta 1Year

Very High Volatility

Syncom Formulation (India) Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Syncom Formulation (India) Ltd. on BSE

Search Inside the pdf :

Syncom Formulation (India) Ltd.

17 Apr 2025

15.42

-0.96%

Company Update

Syncom Formulations India Ltd-$ - 524470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Certificate for Compliance of Regulation 74(5) of SEBI, DP REG 2018 for the Quarter ended 31.03.2025

Syncom Formulation (India) Ltd.

05 Apr 2025, 06:04PM

15.42

-0.96%

Company Update

Syncom Formulations India Ltd-$ - 524470 - Announcement Under Regulation 30

BSE India

Announcement under Regulation 30 for the demand raised under section 74 (5) of CGST ACT, 2017

Syncom Formulation (India) Ltd.

25 Mar 2025

15.42

-0.96%

SAST

Syncom Formulations India Ltd-$ - 524470 - Closure of Trading Window

BSE India

We would inform you that pursuant to SEBI (PIT) Reg, 2015 as amended from time to time, the trading window shall remain close from 1st April, 2025 till completion of 48 hours after the declaration of Audited Standalone and Consolidated Financial result for the quarter and year ended on 31st March, 2025.

Syncom Formulation (India) Ltd.

13 Feb 2025

15.42

-0.96%

Corp. Note

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Disclosure under Regulation 30A of LODR

BSE India

We are Pleased to Inform the Installation of Solar Rooftop Project for Captive Consumption

Syncom Formulation (India) Ltd.

11 Feb 2025

15.42

-0.96%

Company Update

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Intimation for Newspaper Publication for Financials for the quarter ended 31.12.2024 in compliance of Regulation 47(1)(b)

Syncom Formulation (India) Ltd.

10 Feb 2025

15.42

-0.96%

Corp. Note

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Integrated Filing (Financial)

BSE India

Pursuant to SEBI Circular No SEBI/HO/CFD/CFD-POD-2/CIR/P/2024/185 DATED 31.12.2024 We are submitting herewith the integrated Filing financials for the quarter and nine months ended 31.12.2024

Syncom Formulation (India) Ltd.

10 Feb 2025

15.42

-0.96%

Result

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Regulation 33(3) Of SEBI (LODR) Regulations, 2015 - Submission …

BSE India

Consideration and approval of standalone and consolidated unaudited financial results for the quarter and nine months ended 31.12.2024

Syncom Formulation (India) Ltd.

03 Feb 2025

15.42

-0.96%

Corp. Note

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Compliances-Reg. 50 (1) - Prior intimation about Board meeting …

BSE India

Prior Intimation of Board Meeting

Syncom Formulation (India) Ltd.

21 Jan 2025

15.42

-0.96%

Company Update

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Certificate of Compliance of Reg 74(5) of SEBI(DP) REG, 2018 for the quarter ended 31st December, 2024

Syncom Formulation (India) Ltd.

26 Dec 2024

15.42

-0.96%

SAST

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Closure of Trading Window

BSE India

Closure of Trading Closure for the quarter ended 31.12.2024

Is Syncom Formulation (India) Ltd. worth buying?

867 Votes:

Buy 84.08%

Sell 8.19%

Hold 7.73%